This opportunity is closed. Review the award details to understand pricing and competitors for future similar contracts.
This listing does not include downloadable attachments. The solicitation details may be in the description below.
Verify on SAM.govThis acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV monovalent vaccine. This contract was awarded on a hybrid cost reiumbursement/fixed price basis as circumstances do not allow the agency to define its
requirements sufficiently to allow for a fixed-price type contract. Yifan Yang Alternative
Point of Contact Greg Smith Contracting ’NEILL HOUSE (No Street Address
2) WASHINGTON, DC 20515 USA to this opportunity.
Get matched to contracts like this daily
Free AI-powered contract matching for your business.